Karen Midthun plans to retire as director of the Center for Biologics Evaluation and Research, leaving FDA about three months to find a replacement.
Midthun, who became acting center director in 2009 and then permanent director in 2010,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?